検索結果 - Kurt Cooper

  • 検索結果 1 - 3 結果 / 3
結果の絞り込み
  1. 1
    Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever

    Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever 著者: Tiago Abreu-Mota, Katie R. Hagen, Kurt Cooper, Peter B. Jahrling, Gene S. Tan, Christoph Wirblich, Reed F. Johnson, Matthias J. Schnell

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models

    An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Model... 著者: Reed F. Johnson, Drishya Kurup, Katie R. Hagen, Christine R. Fisher, Rohan Keshwara, Amy B. Papaneri, Donna L. Perry, Kurt Cooper, Peter B. Jahrling, Jonathan T. Wang, Jan ter Meulen, Christoph Wirblich, Matthias J. Schnell

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene

    A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene 著者: Yíngyún Caì, Chengjin Ye, Benson Yee Hin Cheng, Aitor Nogales, Masaharu Iwasaki, Shuǐqìng Yú, Kurt Cooper, David X. Liu, Randy Hart, Ricky Adams, Tyler Brady, Elena Postnikova, Jonathan Kurtz, Marisa St. Claire, Jens H. Kuhn, Juan Carlos de la Torre, Luis Martínez‐Sobrido

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: